Literature DB >> 6422579

Monoclonal antibodies to factor IX: characterization and use in immunoassays for factor IX.

K J Smith, K Ono.   

Abstract

Monoclonal antibodies to factor IX have been characterized for potential use in purification of factor IX and for analysis of factor IX abnormalities seen in hemophilia B and other conditions. The properties of six monoclonal antibodies to factor IX are summarized in this report. Antibodies were selected for diverse reactions with factor IX and activated factor IX and which had been transferred to nitrocellulose. Two antibodies showed preference for the heavy chain of activated factor IX, one antibody showed preference for the intact factor IX molecule while three antibodies reacted with the heavy chain of activated factor IX and the intact factor IX molecule equally. Five monoclonal antibodies inhibited factor IX clotting activity. Two antibodies, most specific for factor IX by competitive binding assays, have proved to be useful in immunoassays for factor IX antigen in normal plasmas and in samples from hemophilia B patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6422579     DOI: 10.1016/0049-3848(84)90182-8

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Monoclonal antibodies to coagulation factor IX define a high-frequency polymorphism by immunoassays.

Authors:  K J Smith
Journal:  Am J Hum Genet       Date:  1985-07       Impact factor: 11.025

2.  Polymorphism of normal factor IX detected by mouse monoclonal antibodies.

Authors:  A Wallmark; R Ljung; I M Nilsson; L Holmberg; U Hedner; M Lindvall; H O Sjögren
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

3.  Three point mutations in the factor IX genes of five hemophilia B patients. Identification strategy using localization by altered epitopes in their hemophilic proteins.

Authors:  S H Chen; A R Thompson; M Zhang; C R Scott
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines.

Authors:  S Jallat; F Perraud; W Dalemans; A Balland; A Dieterle; T Faure; P Meulien; A Pavirani
Journal:  EMBO J       Date:  1990-10       Impact factor: 11.598

5.  The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX.

Authors:  D J Rees; I M Jones; P A Handford; S J Walter; M P Esnouf; K J Smith; G G Brownlee
Journal:  EMBO J       Date:  1988-07       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.